Polar Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,312,723
| Closed | -$17.7M | – | 284 |
|
|
2019
Q3 | $17.7M | Hold |
3,312,723
| – | – | 0.16% | 155 |
|
|
2019
Q2 | $21.8M | Hold |
3,312,723
| – | – | 0.19% | 143 |
|
|
2019
Q1 | $21.5M | Hold |
3,312,723
| – | – | 0.2% | 143 |
|
|
2018
Q4 | $22.6M | Buy |
3,312,723
+501,207
| +18% | +$3.42M | 0.24% | 125 |
|
|
2018
Q3 | $18.7M | Buy |
2,811,516
+211,316
| +8% | +$1.4M | 0.16% | 153 |
|
|
2018
Q2 | $14.6K | Buy |
2,600,200
+100,200
| +4% | +$564 | 0.09% | 173 |
|
|
2018
Q1 | $13M | Buy |
2,500,000
+200,000
| +9% | +$1.04M | 0.13% | 164 |
|
|
2017
Q4 | $10.4M | Buy |
2,300,000
+681,648
| +42% | +$3.09M | 0.11% | 161 |
|
|
2017
Q3 | $10.1M | Buy |
1,618,352
+435,080
| +37% | +$2.73M | 0.11% | 157 |
|
|
2017
Q2 | $7.25M | Buy |
+1,183,272
| New | +$7.25M | 0.1% | 165 |
|